HCPCS Codes Similar to KQ

HCPCS Codes Similar to “KQ” Code.
Second or subsequent drug of a multiple drug unit dose formulation

E2510 Speech generating device, synthesized speech, permitting multiple methods of message formulation and multiple methods of device access Code added date: 20040101 Code effective date: 20190101 TXT \| PDF \| XML \| JSON	KP First drug of a multiple drug unit dose formulation Code added date: 19970401 Code effective date: 19970401 TXT \| PDF \| XML \| JSON
KO Single drug unit dose formulation Code added date: 19970401 Code effective date: 19970401 TXT \| PDF \| XML \| JSON	G0270 Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes Code added date: 20030101 Code effective date: 20030101 TXT \| PDF \| XML \| JSON
G0271 Medical nutrition therapy, reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition, or treatment regimen (including additional hours needed for renal disease), group (2 or more individuals), each 30 minutes Code added date: 20030101 Code effective date: 20030101 TXT \| PDF \| XML \| JSON	Q0512 Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period Code added date: 20060101 Code effective date: 20090101 TXT \| PDF \| XML \| JSON
M0236 Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, not otherwise classified, second dose Code added date: 20251001 Code effective date: 20251001 TXT \| PDF \| XML \| JSON	M0238 Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose Code added date: 20250124 Code effective date: 20250124 TXT \| PDF \| XML \| JSON
M0250 Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, includes infusion and post administration monitoring, second dose Code added date: 20210624 Code effective date: 20210624 TXT \| PDF \| XML \| JSON	M1238 Documentation that administration of second recombinant zoster vaccine could not occur during the performance period due to the recommended 2-6 month interval between doses (i.e, first dose received after october 31) Code added date: 20240101 Code effective date: 20240101 TXT \| PDF \| XML \| JSON
G0431 Drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounter Code added date: 20100101 Code effective date: 20160101 TXT \| PDF \| XML \| JSON	A9153 Multiple vitamins, with or without minerals and trace elements, oral, per dose, not otherwise specified Code added date: 20050101 Code effective date: 20050101 TXT \| PDF \| XML \| JSON
P9023 Plasma, pooled multiple donor, solvent/detergent treated, frozen, each unit Code added date: 20000101 Code effective date: 20010101 TXT \| PDF \| XML \| JSON	P9070 Plasma, pooled multiple donor, pathogen reduced, frozen, each unit Code added date: 20160101 Code effective date: 20160101 TXT \| PDF \| XML \| JSON